Delveinsight Business Research LLP
The Hemophilia A therapeutic market is anticipated to grow in the coming years owing to the rise in healthcare spending worldwide and the launch of em… Read More
– Mean Annualized Bleed Rate Reduced by 80% from Baseline and Factor VIII Usage Reduced by 94% in Year 3 Compared to Baseline
– 92% of Patients off Prophylaxis at the En… Read More
New Jersey, United States,- Glycobiology (Diagnostics and Therapeutics) Market research report categorizes the competitive spectrum of the industry in detail. It highlights the top key… Read More
Viral Vectors And Plasmid DNA Manufacturing Industry Overview
The global viral vectors and plasmid DNA manufacturing market size was valued at USD 2.87 billion in 2021 and is expected to ex… Read More
Valoctocogene roxaparvovec conferred sustained bleeding control at 2 years among a cohort of men with severe hemophilia A, according to phase 3 study results published in The New England Jou… Read More
The phenylketonuria treatment market is expected to register a CAGR of around 11 % over the forecast period. The growing burden of phenylketonuria disease and the novel treatments emerging r… Read More
A representative of the pharmaceutical company BioMarin, INC, told Oppenheimer analysts that they had lowered their forecasts for the earnings per share that BioMarin Pharmaceutical would ge… Read More
Check out the companies making headlines in midday trading.
An Apple store on Nanjing Road Pedestrian Street in Shanghai, China, on December 16, 2022.
CFOTO | Future Publishing | Gett… Read More
The Phenylketonuria market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Phen… Read More
Hemophilia
Gene Therapy Market, by Hemophilia Type (Hemophilia A and Hemophilia B), and by
Region (North America, Latin America, Europe, Asia Pacific, Middle East, and
Africa)- Size, S… Read More
Research Nester published a report titled “Congenital Anomalies Treatment Market: Global Demand Analysis & Opportunity Outlook 2031” which delivers detailed overview of… Read More
On May 1, 2023, BioMarin Pharmaceutical’s last quarterly earnings report was released, revealing some surprising numbers. The biotechnology company reported $0.11 earnings per share (E… Read More
According to the research report, the global adeno associated virus vector manufacturing market size is expected to touch USD 6.64 Billion by 2032, from USD 0.84 Billion in 2022… Read More
On May 5, 2023, it was reported that Duality Advisers LP had reduced its position in BioMarin Pharmaceutical Inc. by over 43%. The biotechnology company’s stock worth $1,302,000 saw a… Read More
Marinus Pharmaceuticals, Inc. MRNS, a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced the appointment of Sarah… Read More
On Thursday, it was revealed that Raymond James Financial Services Advisors Inc. increased its holding in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) by 4.9% in the fourth quarter, accordin… Read More
Top Biotech Companies in the USA: Revolutionizing the Future of Healthcare
Discover the top biotech companies in the USA that are spearheading innovation and transforming the healthcare indu… Read More
For episode 34, we sit down with Bruno Gagnon [gag-nan], SVP of Global Clinical Operations at Opthea. Learn about how Opthea is working to better the quality of life for those suffering impa… Read More
CHICAGO — Adding ribociclib (Kisqali) to adjuvant endocrine therapy significantly improved invasive disease-free survival (iDFS) in patients with early-stage, high-risk breast canc… Read More
Congenital Anomalies Treatment Market report which delivers detailed overview of the global congenital anomalies treatment market in terms of market segmentation by type, treatment, end-user… Read More
Congenital Anomalies Treatment Market report which delivers detailed overview of the global congenital anomalies treatment market in terms of market segmentation by type, treatment… Read More
It is possible for transthyretin amyloid cardiomyopathy (ATTR-CM, also called cardiac ATTR amyloidosis) to be reversed with antibody treatment, as suggested by rare cases of patients who h… Read More
The ‘Global Pompe Disease Treatment Market Size, Share, Price, Growth, Key Players, Analysis, Report and Forecast 2023-2031’ by Expert Market Research gives an extensive outlook… Read More
Congenital Anomalies Treatment Market report which delivers detailed overview of the global congenital anomalies treatment market in terms of market segmentation by type, treatment… Read More
Congenital Anomalies Treatment Market report which delivers detailed overview of the global congenital anomalies treatment market in terms of market segmentation by type, treatment… Read More
Congenital Anomalies Treatment Market report which delivers detailed overview of the global congenital anomalies treatment market in terms of market segmentation by type, treatment… Read More
Download Full Report Here
Introduction
The Medical Affairs Professional Society (MAPS) is pleased to share our 2023 Medical Metrics Benchmarking Report. This Report… Read More
The gene therapy market size is poised to grow by $ 15.68 billion by 2030 from $ 3.59 Billion in 2022, exhibiting a CAGR of 20.2% during the forecast period 2022-2030.
The Gene therap… Read More
Andreas Halvorsen (Trades, Portfolio), the chief investment officer of Viking Global Investors, disclosed earlier this week he reduced his stake in Roivant Sciences Ltd. (ROIV, Financial)… Read More
The FDA approved valoctocogene roxaparvovec (Roctavian) as the first gene therapy for the treatment of adults with severe hemophilia A, drug developer Biomarin announced on Thursday.
Patie… Read More
It’s been a big week for cell and gene therapy approvals in the US, including a much-awaited approval for one to treat hemophilia A, the most common form of hemophilia. The US Food and… Read More
Hemophilia A Market
DelveInsight’s “Hemophilia A- Market Insights, Epidemiology and Market Forecast– 2032” report delivers an in-depth understanding of the Hemop… Read More
hemophilia factor deficiency :: Article CreatorFDA Approves First Gene Therapy For Severe Hemophilia A The U.S. Food and Drug Administration on Thursday approved… Read More
factor vii deficiency treatment :: Article CreatorHemab Therapeutics Presents New Preclinical Research Demonstrating Effects Of Its Bispecific Antibody HMB-001 In Fa… Read More
hemophilia genetic disorder :: Article CreatorBioMarin's Next Roctavian Challenge Is How To Successfully Commercialize Its Gene Therapy: Warranties May Be An Option… Read More
Whole genome sequencing captured almost twice as many genetic abnormalities that may be responsible for disease in infants, compared with a standard targeted test, researchers found.
In th… Read More
blood diseases hemophilia :: Article CreatorFDA Approves First Gene Therapy For Severe Hemophilia A The U.S. Food and Drug Administration on Thursday approved a c… Read More
hemophilia and dentistry :: Article Creator$2.9 Million Gene Therapy For Severe Hemophilia Is Approved By FDAWASHINGTON -- U.S. Officials on Thursday approved drugma… Read More
hemophilia factor deficiency :: Article CreatorAbnormal Uterine Bleeding May Be Caused By Clotting Factor DeficienciesA new review article illuminates why physicians… Read More
causes haemophilia :: Article CreatorWoman Told She Won't Live Past 35 As She Lives With Six Medical Conditions Hanna Hamm is a ticking medical time bomb — th… Read More
The biotech industry is poised for a remarkable ascent in the coming years, fueling extraordinary advancements across diverse sectors and transforming the way we live, heal, and interact wit… Read More
In a world where health is paramount, the pharmaceutical industry stands as a formidable pillar, relentlessly pursuing scientific breakthroughs and life-saving innovations. With each passing… Read More
Achondroplasia Therapeutics Market Report has recently added by Value Market Research, this surveillance report establishing the facts based on current scenarios, historical records from 202… Read More
Introducing Vial CRO’s ‘First in Human: The Panel Series’
As a global tech-forward CRO (contract research organization), Vial is committed to leveraging innovative techn… Read More
The gene therapy market size is poised to grow by $ 15.68 billion by 2030 from $ 3.59 Billion in 2022, exhibiting a CAGR of 20.2% during the forecast period 2022 to 2030.
Key Ta… Read More
Compared with on-demand treatment, prophylaxis with concizumab — designed to achieve hemostasis in all hemophilia types — reduced annualized bleeding rates among patients w… Read More
The AAV Vectors in Gene Therapy Pipeline Insight 2023 report by DelveInsight offers a thorough global overview of AAV Vectors in Gene Therapy treatments, including those already in the mark… Read More
(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Primary Hyperoxaluria pipeline constitutes 8+ key companies continuously working towards developing 8+… Read More
Achondroplasia Treatment Market
Achondroplasia is the most common of skeletal dysplasia that results in marked short stature (dwarfism). It is a human bone genetic disorder of the growt… Read More
Vial CRO’s ‘First in Human: The Panel Series’
As a global tech-forward CRO (contract research organization), Vial is committed to leveraging innovative technology soluti… Read More
If the integration of natural sciences and engineering sciences interests you, a Master’s in Biotechnology in the UK is the path for you. It offers a deep dive into the study of biote… Read More
In 2021, the global gene therapy market was estimated to be worth $1.55 billion USD. The market is expected to increase from US$ 1.85 billion in 2022 to US$ 10.1 billion by 2032, at an 18.5%… Read More
Early emicizumab (Hemlibra) prophylaxis alone prevented clinically relevant bleeds in patients with newly diagnosed acquired hemophilia A, while avoiding the infectious complications of im… Read More
Note that some links may require registration or subscription.
The Supreme Court said the Biden administration can temporarily continue to request removal of misleading content, like medic… Read More
Law enforcement and public health officials say a surge in counterfeit versions of drugs that help with weight loss like semaglutide (Ozempic, Wegovy) may be the worst since counterfeit er… Read More